February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
5 new drug indications by FDA Oncology in the last 10 days – Oncology Brothers
Nov 21, 2023, 14:18

5 new drug indications by FDA Oncology in the last 10 days – Oncology Brothers

Quoting Oncology Brothers on X/Twitter:

“What just happened?
5 new drug indications by FDA Oncology in the last 10 days. As Community Oncologists, we need to know them all:

1. Fruquintinib in refractory mCRC, mPFS 3.7mos vs 1.8mos.

2. Pembrolizumab (+Chemo) in 1L mGEJ/Gastric Ca, mOS 12.9mos Vs 11.5mos.

3. Capivasertib (+Fulvestrant) in PIK3CA/AKT1/PTEN +ve metastatic HR+ Breast Ca after >1 endocrine Rx, mPFS 7.2mos Vs 3.6mos.

4. Repotrectinib in 1L mNSCLC ROS1 +ve, ORR 79% and mDoR 34mos.

5. Enzalutamide (+/- ADT) in non-Mets HSPC, 5 year MFS: 87.3% (combo) Vs 80% (Enza monotherapy) Vs 71.4% (ADT alone).”

Source: Oncology Brothers/Twitter